$1.22 Billion is the total value of IRIDIAN ASSET MANAGEMENT LLC/CT's 48 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2023 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-04-28
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
WYNDHAM WORLDWIDE CORP | 31 | Q4 2020 | 4.8% |
WR GRACE & CO | 30 | Q3 2020 | 5.0% |
VISTEON CORP | 30 | Q3 2021 | 2.9% |
POST HOLDINGS INC. | 29 | Q3 2023 | 5.4% |
LABORATORY CORP OF AMERICA HOLDINGS | 29 | Q3 2023 | 4.7% |
UNIVAR USA INC | 29 | Q2 2023 | 4.6% |
HALOZYME THERAPEUTICS INC | 29 | Q3 2020 | 1.8% |
FLEXTRONICS INTL LTD | 27 | Q3 2023 | 5.1% |
BALL CORPORATION | 27 | Q4 2022 | 3.3% |
INTERCONTINENTAL EXCHANGE INC | 25 | Q3 2023 | 3.6% |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Axsome Therapeutics, Inc. | January 18, 2022 | ? | ? |
Katapult Holdings, Inc. | January 18, 2022 | ? | ? |
Travel & Leisure Co. | January 18, 2022 | ? | ? |
Chemours Co | January 28, 2020 | ? | ? |
HALOZYME THERAPEUTICS, INC. | January 28, 2020 | ? | ? |
MEDICINES CO /DE | January 28, 2020 | ? | ? |
Univar Solutions Inc. | January 28, 2020 | ? | ? |
VISTEON CORP | November 04, 2019 | ? | ? |
ALLEGHENY TECHNOLOGIES INC | February 06, 2019 | ? | ? |
ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. | February 06, 2019 | ? | ? |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-01 |
13F-HR | 2024-01-26 |
SC 13G/A | 2024-01-24 |
13F-HR | 2023-10-30 |
13F-HR | 2023-08-09 |
13F-HR | 2023-04-28 |
SC 13G | 2023-02-03 |
13F-HR | 2023-01-31 |
13F-HR | 2022-11-07 |
13F-HR | 2022-07-29 |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.